Koen Andries

20.3k total citations · 4 hit papers
156 papers, 14.2k citations indexed

About

Koen Andries is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Koen Andries has authored 156 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Infectious Diseases, 81 papers in Epidemiology and 41 papers in Molecular Biology. Recurrent topics in Koen Andries's work include Tuberculosis Research and Epidemiology (58 papers), HIV Research and Treatment (35 papers) and HIV/AIDS drug development and treatment (34 papers). Koen Andries is often cited by papers focused on Tuberculosis Research and Epidemiology (58 papers), HIV Research and Treatment (35 papers) and HIV/AIDS drug development and treatment (34 papers). Koen Andries collaborates with scholars based in Belgium, United States and France. Koen Andries's co-authors include Nacer Lounis, Jérôme Guillemont, Anil Koul, Rudi Pauwels, Vincent Jarlier, Éric Arnoult, Paul A. J. Janssen, Peter Verhasselt, Emma Huitric and Dirk Bald and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Koen Andries

154 papers receiving 13.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis

2004 1.6k citations Koen Andries, Peter Verhasselt et al. Science profile →
The challenge of new drug discovery for tuberculosis

2011 831 citations Anil Koul, Nacer Lounis et al. Nature profile →
Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

1990 673 citations Rudi Pauwels, Koen Andries et al. Nature profile →
Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline

2014 505 citations Alexander S. Pym, I. А. Vаsilyevа et al. profile →

Peers

Countries citing papers authored by Koen Andries

Since Specialization

Citations

This map shows the geographic impact of Koen Andries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koen Andries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koen Andries more than expected).

Fields of papers citing papers by Koen Andries

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koen Andries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koen Andries. The network helps show where Koen Andries may publish in the future.

Co-authorship network of co-authors of Koen Andries

This figure shows the co-authorship network connecting the top 25 collaborators of Koen Andries. A scholar is included among the top collaborators of Koen Andries based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koen Andries. Koen Andries is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Minimal effective dose of bedaquiline administered orally and activity of a long acting formulation of bedaquiline in the murine model of leprosy 2023 ·PLoS neglected tropical diseases ·Aurélie Chauffour, Nacer Lounis, Koen Andries, Vincent Jarlier, Nicolas Véziris, Alexandra Aubry	5
2	Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678 2023 ·Scientific Reports ·(unknown), (unknown), Nele Coeck, Wim Mulders, Oren Tzfadia, Bouke C. de Jong, Koen Andries, Leen Rigouts	9
3	Efficacy of Long-Acting Bedaquiline Regimens in a Mouse Model of Tuberculosis Preventive Therapy 2021 ·American Journal of Respiratory and Critical Care Medicine ·Amit Kaushik, Nicole C. Ammerman, Rokeya Tasneen, Sophie Lachau‐Durand, Koen Andries, Eric L. Nuermberger	9
4	Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trial 2018 ·PLoS ONE ·Paul Meyvisch, (unknown), Koen Andries, Nacer Lounis, (unknown), Brian Dannemann, An Vandebosch, Wim Van der Elst, Geert Molenberghs, Ariel Alonso	10
5	Synthesis and evaluation of analogues of the tuberculosis drug bedaquiline containing heterocyclic B-ring units 2017 ·Bioorganic & Medicinal Chemistry Letters ·Peter J. Choi, Hamish S. Sutherland, Amy S.T. Tong, Adrian Blaser, Scott G. Franzblau, Christopher B. Cooper, (unknown), Anna M. Upton, Jérôme Guillemont, (unknown), Laurence Quéguiner, Koen Andries, (unknown), William A. Denny, Brian D. Palmer	48
6	In vitro culture conditions affecting minimal inhibitory concentration of bedaquiline against M. tuberculosis 2016 ·Médecine et Maladies Infectieuses ·Nacer Lounis, Luc Vranckx, Tom Gevers, Koné Kaniga, Koen Andries	17
7	Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis 2015 ·European Respiratory Journal ·Alexander S. Pym, Andreas H. Diacon, Shenjie Tang, Francesca Conradie, Manfred Danilovitš, Charoen Chuchottaworn, I. А. Vаsilyevа, Koen Andries, Nyasha Bakare, Tine De Marez, (unknown), Nacer Lounis, Paul Meyvisch, Ben Van Baelen, Rolf P. G. van Heeswijk, Brian Dannemann	226
8	Short-Course Chemotherapy with TMC207 and Rifapentine in a Murine Model of Latent Tuberculosis Infection 2011 ·American Journal of Respiratory and Critical Care Medicine ·Tianyu Zhang, Si-Yang Li, Kathy N. Williams, Koen Andries, Eric L. Nuermberger	47
9	Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model 2010 ·European Respiratory Journal ·Wieslawa Olszewska, Gabriela Ispas, Corinna Schnoeller, (unknown), Tom Van de Casteele, David Nauwelaers, (unknown), Dirk Roymans, Marc De Meulder, M.C. Rouan, P. Van Remoortere, Jean‐François Bonfanti, (unknown), A. Koul, (unknown), Koen Andries, (unknown), Belinda Wang, Peter Openshaw, René Verloes	42
10	Sterilizing Activity of R207910 (TMC207)-containing Regimens in the Murine Model of Tuberculosis 2009 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), C. Truffot-Pernot, Koen Andries, Vincent Jarlier, Nicolas Véziris	61
11	A Once-Weekly R207910-containing Regimen Exceeds Activity of the Standard Daily Regimen in Murine Tuberculosis 2008 ·American Journal of Respiratory and Critical Care Medicine ·Nicolas Véziris, (unknown), Nacer Lounis, Aurélie Chauffour, C. Truffot-Pernot, Koen Andries, Vincent Jarlier	51
12	Diarylquinolines target subunit c of mycobacterial ATP synthase 2007 ·Nature Chemical Biology ·Anil Koul, Najoua Dendouga, Karen Vergauwen, (unknown), Luc Vranckx, Rudy Willebrords, Zorica Stanojević-Ristić, Holger Lill, Ismet Dorange, Jérôme Guillemont, Dirk Bald, Koen Andries	433
13	A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis breakdown → 2004 ·Science ·Koen Andries, Peter Verhasselt, Jérôme Guillemont, Hinrich W. H. Göhlmann, Jean‐Marc Neefs, Hans Christian Winkler, Jef Van Gestel, Philip Timmerman, Min Zhu, (unknown), Peter Williams, (unknown), Emma Huitric, Sven Hoffner, Emmanuelle Cambau, C. Truffot-Pernot, Nacer Lounis, Vincent Jarlier	1632
14	Evolution of Anti-HIV Drug CandidatesPart 2: Diaryltriazine (DATA) Analogues 2001 ·Bioorganic & Medicinal Chemistry Letters ·Donald Ludovici, Robert W. Kavash, Michael J. Kukla, Chih Y. Ho, Hong Ye, (unknown), Koen Andries, Marie‐Pierre de Béthune, Hilde Azijn, Rudi Pauwels, (unknown), Jan Heeres, Lucien M. H. Koymans, Marc R. de Jonge, Koen Van Aken, (unknown), Paul Lewi, Kalyan Das, Eddy Arnold, Paul A. J. Janssen	98
15	Evaluation of the efficacy and tolerance of R 018893, R 089439 (loviride) and placebo in asymptomatic HIV-1-infected patients 1996 ·Antiviral Therapy ·Schlomo Staszewski, Veronica Miller, (unknown), Robert Colebunders, Bernard Vandercam, J Delescluse, Nathan Clumeck, Filip Van Wanzeele, Marc De Brabander, J. De Crée, Marc Moeremans, Koen Andries, Charles A. Boucher, Paul Stoffels, Paul A. J. Janssen	5
16	Crystal Structures of 8-Cl and 9-Cl TIBO Complexed with Wild-type HIV-1 RT and 8-Cl TIBO Complexed with the Tyr181Cys HIV-1 RT Drug-resistant Mutant 1996 ·Journal of Molecular Biology ·Kalyan Das, Jianping Ding, Y. Hsiou, Arthur D. Clark, Henri Moereels, Luc Koymans, Koen Andries, Rudi Pauwels, Paul A. J. Janssen, Paul L. Boyer, Patrick K. Clark, Richard H. Smith, Marilyn B. Kroeger Smith, Christopher J. Michejda, Stephen H. Hughes, Eddy Arnold	159
17	Characterization of HIV-1 Strains Isolated from Patients Treated with TIBO R82913 1994 ·AIDS Research and Human Retroviruses ·Anne–Mieke Vandamme, Zeger Debyser, Rudi Pauwels, K De Vreese, Patrick Goubau, Mike Youle, Brian Gazzard, Paul Stoffels, G. Cauwenbergh, Jozef Anné, Koen Andries, Paul A. J. Janssen, Jan Desmyter, Erik De Clercq	36
18	TIBO R82913, A New HIV-1 Inhibiting Agent, Does Not Inhibit Hematopoietic Progenitor Cells 1991 ·AIDS Research and Human Retroviruses ·R. G. Geißler, Arnold Ganser, Oliver G. Ottmann, G. Kojouharoff, (unknown), Koen Andries, K H Schellekens, D. Hoelzer	1
19	Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives breakdown → 1990 ·Nature ·Rudi Pauwels, Koen Andries, Jan Desmyter, Dominique Schols, Michael J. Kukla, Henry J. Breslin, (unknown), (unknown), Robert Woestenborghs, J. Heykants, K H Schellekens, M. Janssen, Erik De Clercq, Paul A. J. Janssen	673
20	Effect of Experimental Infection with Pseudorabies (Aujeszky's Disease) Virus on Pigs with Maternal Immunity from Vaccinated Sows 1978 ·American Journal of Veterinary Research ·Koen Andries, Maurice Pensaert, (unknown)	63

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact